CYP19A1 and ovarian carcinoma: Several other reports have shown that antiestrogens or aromatase inhibitors cause estrogen deprivation resulting in cell cycle arrest at the G1 phase by inducing p53, p21, and p27 inhibitors of cyclin-dependent kinases in the breast as well as ovarian cancers (Cariou et al., 2000).